Depo-Provera brain tumor screening is becoming increasingly important as studies continue examining possible links between prolonged hormonal contraceptive exposure and meningioma diagnoses. Former users are now seeking neurological evaluations, MRI scans, and early detection strategies to better protect long-term brain health.
















